Mind Cure Health (CSE: MCUR) has shaken up its management team slightly, promoting COO Kelsey Ramsden to the role of President and Chief Executive Officer of the company, effective immediately. Former President and CEO Philip Tapley will remain with the company however, where he will continue to serve as Chairman of the board.
Ramsden, previously COO of Mind Cure, is an experienced entrepreneur, having twice won Canada’s Top Female Entrepreneur of the Year. She is said to have built multiple eight-figure companies, and has been named as one of Canada’s 100 most powerful women while also serving as a Richard Branson Centre Mentor.
In his transition to that of predominantly serving as Chairman of the board, Tapley commented on Ramsden’s appointment by stating, “Mrs. Ramsden will take our strategic vision to new heights. We have earned the trust of the industry and our shareholders these past few months, and now we get to work to translate that into earning the trust of our customers and those in need of new mental health treatments. Mrs. Ramsden has the full support of our Board of Directors and the right strategic plan in place for Mind Cure to become an industry leader.”
“This growing industry of psychedelics and new mental health treatments requires a paradigm shift away from the old way of doing things. I have done things differently as a leader throughout my career. This industry needs more individualization. Richer scientific rigor. More empathy and trust that is earned. This is how I plan to lead Mind Cure.”
Kelsey Ramsden, President & CEO of Mind Cure Health
Mind Cure Health last traded at $0.63 on the CSE.
FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.
